Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 4535

BillFederalSenateIntroduced
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
About This Bill
Introduced
Introduced
July 14, 2022
Cosponsors (0)
None
View PDF ↗

Full Text

The official full text of this bill isn’t available inside AllCiv yet. Read it on Congress.gov:

A plain-language summary is on the Summary tab — you can highlight and annotate it there.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.